Primary malignant melanoma, of head and neck: A comprehensive review of literature

Oral Oncology

Volumn 48, Issue 5, 2012, Pages 399-403

  Vikey, A K ^a   Vikey, Deepali ^b  

^a Sri Aurobindo College of Dentistry   (India)

^b Sri Aurobindo College of Dentistry   (India)

Author keywords

IL 2; Immunotherapy; Malignant melanoma; Molecular biomarkers; Multidisciplinary approach; Positron emission tomography; S 100 and HBM 45; Tanning beds; Ultraviolet radiation (UVR)

Indexed keywords

CARCINOGEN; CISPLATIN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERLEUKIN 2; INTERLEUKIN 24; LACTATE DEHYDROGENASE; MYC PROTEIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN P53; PROTEIN S100B; STAT3 PROTEIN; SUNSCREEN; SUPPRESSOR OF CYTOKINE SIGNALING 3; VASCULOTROPIN; VINDESINE; WNT5A PROTEIN;

AWARENESS; BIOTECHNOLOGY; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER MORTALITY; CANCER PREVENTION; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURVIVAL; CLINICAL FEATURE; EARLY DIAGNOSIS; GLOBAL CLIMATE; HEAD AND NECK TUMOR; HISTOPATHOLOGY; HUMAN; MELANOMA; PATHOGENESIS; PRIMARY TUMOR; PRIORITY JOURNAL; REVIEW; SENTINEL LYMPH NODE BIOPSY; TUMOR VOLUME;

ANTINEOPLASTIC AGENTS; BEAUTY CULTURE; HEAD AND NECK NEOPLASMS; HUMANS; MELANOMA; RISK FACTORS; SUNLIGHT;

EID: 84859961678     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2011.12.014     Document Type: Review

References (28)

1. Papaspyrou Giorgios, Garbe Claus, Schadendrof Drik, Jochen A, Hauschild Axel, Egberts Friederike. Mucosal melanomas of the head and neck: new aspects of the clinical outcome molecular pathology and treatment with C-kit inhibitors**. Melanoma Res 2011;21(6):475-82.
2. Sandby-Moller Jane, Thieden Elisabeth, Philipsen Peter Alshede, Schmidt Hars Christian, Wulf Hars Christian. Dermal echogenicity: a biological indicator of individual cumulative UVR exposure? Arch Dermatol Res 2004;295(11):498-504.
3. WHO. Artificial tanning sun beds: risk and guidance. WHO.int. retrieved 29.07.09.
4. Bosserhoff AK. Novel biomarkers in malignant melanoma. Clin Chim Acta 2006;367(1-2):28-35.
5. Tagaki M, Ishikawa G, Mori W. Primary malignant melanoma of the oral cavity in Japan: with special reference to mucosal melanosis. Cancer 1974;34:358-70.
6. Leiter Ulrike, Garbe Claus. Epidemiology of melanoma and non melanoma skin cancer: the role of sunlight. Adv Exp Med Biol 2008;624:89-103.
7. de Vries Esther, Bray Freddie I, Coeberg Jan Willem W, Parkin Donald M. Changing epidemiology of malignant cutaneous melanoma in Europe 1953-1997; rising trends in incidence and mortality but recent stabilization in Western Europe and decreases in Scandinavia. Int J Cancer 2003;107(1):119-26.
8. Bentham Graham, Aase Asbjorn. Incidence of malignant melanoma of the skin in Norway, 1955-1989: association with solar ultraviolet radiation, income and holidays abroad. Int J Epidemiol 1996;25:1132-8.
9. Waldmann V, Bock M, Jackel A, Deichmann M, Dockndroff K, Naher H. Pathogenesis of malignant melanoma: molecular biology aspect. Hautarzt 1999;50(6):398-405. (Pubitemid 29302428)
10. Trapp Valerie, Lee Kristy, Donate Fernando, Mazar Andrew P, Fruehauf John P. Redox-related antimelanoma activity of ATN-224. Melanoma Res 2009;19(6):350-60.
11. Wu Zeng Sheng, Cheng Xing Wang, Wang Xiao Nan, Song Ning Jing. Prognostic significance phosphorylated signal transducer and activator of transcription 3 and suppressor of cytokine signaling 3 expressions in human cutaneous melanoma. Melanoma Res 2011;21(6):483-90.
12. Mathew A, Kienstra MD, Tapan A, Padhya MD. Head and neck melanoma. Cancer Control 2005;12(4):242-7.
13. Trodahl JN, Sprague WG. Benign and malignant melanotic lesions of the oral mucosa: an analysis of 135 cases. Cancer 1970;25:812-23.
14. Batsaki JG, Regezi JA, Solomen AR, Rice DH. The pathology of head and neck tumors: mucosal melanomas. Head Neck Surg 1982;4:404-8.
15. Henzen-Longmansn SC, Meijer CM, Ruiter DJ, Mullink H, Balm AJM, Show GB. Diagnostic application of panels of antibodies in mucosal melanomas of the head and neck. Cancer 1988;61:702-11. (Pubitemid 18037921)
16. Jen Emily Y, Poindexter Nancy J, Farnsworth Elizabeth S, Grimm Elizabeth A. IL- 2 regulates the expression of the tumor suppressor IL-24 in melanoma cells. Melanoma Res 2011;21(6). doi:10.1097/CMR.0b013e32834d250.
17. Olson RM, Woods JE, Soule EH. Regional lymph node management and outcome in 100 patients with head and neck melanoma. Am J Surg 1981;142:470-3. (Pubitemid 11014481)
18. Hofmann Maja A, Hauschild Axel, Mohr Peter, Garbe Claus, Weichenthal Uwe, Trefzer Uwe, et al. Prospective evaluation of supportive care with or without CVD chemotherapy as a second line treatment in advanced melanoma by patient's choice: a multicentre dermatologic cooperative oncology group trial. Melanoma Res 2011;21(6):516-23.
19. Visus Carmen, Andre Raquel, Mayordomo Jose I, Martinez Lorenzo Maria J, Murillo Laura, Berta Saez G, et al. Prognostic role of circulating melanoma cells detected b reverse transcriptase-polymerase chain reaction for tyrosinase mRNA in patients with melanoma. Melanoma Res 2007;17(2):83-9.
20. Hariharan Vidhya, Toole Timothy, Klarquist Jared, Mosenson Jeffrey, Jack Longley B, Caroline Le Poole I. Topical application of bleaching phenols in vivo studies and mechanism of action relevant to melanoma treatment. Melanoma Res 2011;21(2):115-26.
21. Mouwad Roger, Spano Jean-Philippe, Khayat David. Old and new serological biomarkers in melanoma: where we are in 2009. Melanoma Res 2010;20(2):67-76.
22. Palmer Shanique R, Erikson Lori A, Ichetovkin Ilia, Knaur Daniel J, Markovic Svetomir N. Circulating serologic and molecular biomarkers in malignant melanoma. Mayo Clin Proc 2011;86(10):981-90.
23. Agarwala Sanjiv S. Novel immunotherapies as potential therapeutic partners for traditional or targeted agents: Cytotoxic T-lymphocyte antigen-4 blockade in advanced melanoma. Melanoma Res 2010;20(1):1-10.
24. Breslow A. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg 1970;172:902-8.
25. Abbasi NR, Shaw HM, Rigel DS, et al. Early diagnosis of cutaneous melanoma: revisiting the ABCD criteria. JAMA 2004;292:2771-6. (Pubitemid 39628257)
26. Lachiewicz Anne M, Berwick Marianne, Wiggins Charles L, Thomas Nancy E. Survival differences between patients with scalp or neck melanoma and those with melanoma of other sites in the surveillance, epidemiology and end results (SEER) program. Arch Dermatol 2008;144(4):515-21.
27. Balch CM, Buzaid AC, Soong ST, et al. Final version of the American Joint Committee on cancer staging system for cutaneous melanoma. J Clin Oncol 2001;19:3635-48. (Pubitemid 32786276)
28. Bonnen MD, Ballo MT, Myers JN, et al. Elective radiotherapy provides regional control for patients with cutaneous melanoma of the head and neck. Cancer 2004;100:383-9. (Pubitemid 38063649)